自发性脑出血患者术后短期深度镇静策略:一项随机对照试验
该研究为前瞻性随机平行组研究,纳入2015年12月至2016年11月在首都医科大学大兴教学医院接受开颅手术的成人自发性脑出血患者106例,随机分为短期深度镇静组和轻度中度镇静组各53例。所有患者术后使用舒芬太尼镇痛、咪达唑仑镇静;轻度中度镇静组咪达唑仑0.05-0.10 mg/kg目标RASS -2至1,短期深度镇静组咪达唑仑0.1-0.2 mg/kg目标RASS -4至-3且持续时间不超过12小时。结果显示短期深度镇静组再出血再手术例数、气管切开例数、3个月死亡例数均显著少于轻度中度镇静组,残留血肿体积显著减少,预后良好例数显著增加。作者认为该策略安全有效。
要点
- 短期深度镇静组再出血再手术0例 vs 轻度中度镇静组4例(χ²=4.000,P=0.045)。
- 短期深度镇静组气管切开9例 vs 轻度中度镇静组21例(P<0.05)。
- 短期深度镇静组3个月死亡5例 vs 轻度中度镇静组13例,预后良好39例 vs 12例(均P<0.05)。
- 短期深度镇静组术后2、7、14天残留血肿体积均显著小于轻度中度镇静组(均P<0.05)。
- 短期深度镇静组术后12小时内RASS评分更低、突发躁动次数更少(1次 vs 3次,P<0.01),但镇静持续时间更长(14.0小时 vs 8.9小时,P<0.05)。
适用人群与场景
- 成人自发性脑出血并接受开颅手术的患者,来自首都医科大学大兴教学医院2015年12月至2016年11月收治者。
- 排除年龄大于65岁、休克、术前格拉斯哥昏迷评分(GCS)为3分的患者。
诊断标准与关键阈值
- 镇静深度目标:短期深度镇静组RASS评分-4至-3,持续时间不超过12小时;轻度中度镇静组RASS评分-2至1。
处置流程与药物剂量
- 所有患者术后使用舒芬太尼镇痛、咪达唑仑镇静。
- 轻度中度镇静组:咪达唑仑0.05-0.10 mg/kg,目标RASS评分-2至1。
- 短期深度镇静组:咪达唑仑0.1-0.2 mg/kg,目标RASS评分-4至-3,持续时间不超过12小时。
研究设计与关键结果
- 研究类型为前瞻性随机平行组研究,纳入106例患者,短期深度镇静组和轻度中度镇静组各53例。
- 再出血再手术:短期深度镇静组0例 vs 轻度中度镇静组4例(χ²=4.000,P=0.045)。
- 气管切开:短期深度镇静组9例 vs 轻度中度镇静组21例(P<0.05)。
- 术后12小时内RASS评分:4小时短期深度镇静组-4(-4,-2) vs 轻度中度镇静组-2(-3,-1);8小时-4(-4,-2) vs -1(-2,0);12小时-3(-4,-2) vs 0(-2,1),均P<0.01。
- 突发躁动次数:短期深度镇静组1(0,1)次 vs 轻度中度镇静组3(2,3)次(P<0.01);术后镇静持续时间:短期深度镇静组14.0(8.3,20.8)小时 vs 轻度中度镇静组8.9(3.4,15.3)小时(P<0.05)。
- 术后12小时内收缩压:短期深度镇静组136.8±30.5 mmHg vs 轻度中度镇静组149.1±33.5 mmHg;舒张压:短期深度镇静组85.0(70.8,102.3)mmHg vs 轻度中度镇静组89.0(69.2,116.7)mmHg,均P<0.05。
- 术后24小时动脉血气、血常规、凝血功能两组无显著差异。
- 残留血肿体积:术后2天短期深度镇静组16.4±15.6 mL vs 轻度中度镇静组38.2±22.2 mL;7天9.6±8.7 mL vs 20.6±18.6 mL;14天1.2±1.0 mL vs 4.4±3.6 mL,均P<0.05。
证据类型、等级与局限
- 证据类型:前瞻性随机平行组研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,自发性脑出血开颅术后采用短期深度镇静策略(咪达唑仑0.1-0.2 mg/kg,目标RASS -4至-3,不超过12小时)可减少不良事件发生率并改善预后,安全有效。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the efficacy and safety of short-term deep sedation strategy in patients with spontaneous intracerebral hemorrhage (ICH) after surgery.
METHODS: A perspective, randomized, parallel-group study was conducted. Adult patients with spontaneous ICH and undergoing craniotomy admitted to Daxing Teaching Hospital of Capital Medical University from December 2015 to November 2016 were enrolled. The patients who received surgery were randomly divided into a short-term deep sedation and a slight and middle sedation group. Sufentanil was used as an analgesic drug in all patients and midazolam was used as a sedative after the operation. The patients in the slight and middle sedation group received midazolam 0.05-0.10 mg/kg with a goal of mild sedation [Richmond agitation and sedation scale (RASS) score of -2-1]. The patients in the short-term deep sedation group received midazolam 0.1-0.2 mg/kg with a goal of deep sedation (RASS score of -4 to -3) and a duration of no more than 12 hours. Postoperative sedation, blood pressure changes, laboratory indexes, residual hematoma and clinical outcomes were recorded in two groups.
RESULTS: During the study, a total of 183 patients with spontaneous ICH were collected, excluding who was older than 65 years, with shock, and with preoperative Glasgow coma score (GCS) of 3. 106 patients were enrolled in this study, and 53 patients were assigned to the short-term deep sedation group and slight and middle sedation group, respectively. In the slight and middle sedation group, 4 patients received reoperation because of repeated hemorrhage and no patient operated repeatedly in the short-term deep sedation group, and there was a significant difference between the two groups (χ 2 = 4.000, P = 0.045). The number of patients undergoing tracheotomy in the short-term deep sedation group was significantly lower than that in the slight and middle sedation group (9 cases vs. 21 cases, P < 0.05). RASS score within 12 hours after operation of the patients in the short-term deep sedation group was lower than that in slight and middle sedation group [-4 (-4, -2) vs. -2 (-3, -1) at 4 hours, -4 (-4, -2) vs. -1 (-2, 0) at 8 hours, -3 (-4, -2) vs. 0 (-2, 1) at 12 hours, all P < 0.01], sudden restlessness was significantly reduced [times: 1 (0, 1) vs. 3 (2, 3), P < 0.01], and postoperative sedation duration was significantly prolonged [hours: 14.0 (8.3, 20.8) vs. 8.9 (3.4, 15.3), P < 0.05]. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) within 12 hours after operation in the short-term deep sedation group were significantly lower than those of the slight and middle sedation group [SBP (mmHg, 1 mmHg = 0.133 kPa): 136.8±30.5 vs. 149.1±33.5, DBP (mmHg): 85.0 (70.8, 102.3) vs. 89.0 (69.2, 116.7), both P < 0.05]. There were no significant differences in the arterial blood gas, routine blood test or coagulation function between the two groups at 24 hours after operation. The volume of residual hematoma at 2, 7 and 14 days after operation in the short-term deep sedation group was significantly decreased as compared with slight and middle sedation group (mL: 16.4±15.6 vs. 38.2±22.2 at 2 days, 9.6±8.7 vs. 20.6±18.6 at 7 days, 1.2±1.0 vs. 4.4±3.6 at 14 days, all P < 0.05), number of deaths in 3 months were significantly less (5 cases vs. 13 cases), and the patients with favorable prognosis were increased significantly (39 cases vs. 12 cases, both P < 0.05).
CONCLUSIONS: The study results showed that short-term deep sedation strategy after surgery can reduce the incidence of adverse events and improve the prognosis of patients with spontaneous ICH, so it is safe and effective.
参考来源
- Wang Z, Shi C, Sun L, et al. [Short-term deep sedation strategy in patients with spontaneous intracerebral hemorrhage: a randomized controlled trial]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 29151416. doi:10.3760/cma.j.issn.2095-4352.2017.11.009
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。